Zobrazeno 1 - 10
of 797
pro vyhledávání: '"Peter Ferenci"'
Autor:
Mathias Jachs, Marlene Panzer, Lukas Hartl, Michael Schwarz, Lorenz Balcar, Jeremy V. Camp, Petra Munda, Mattias Mandorfer, Michael Trauner, Stephan W. Aberle, Heinz Zoller, Thomas Reiberger, Peter Ferenci
Publikováno v:
JHEP Reports, Vol 5, Iss 8, Pp 100751- (2023)
Background & Aims: Bulevirtide (BLV) is a novel antiviral drug licensed for the treatment of chronic hepatitis D. Data on the safety and efficacy of stopping BLV therapy upon long-term HDV-RNA suppression are scarce. Methods: A total of seven patient
Externí odkaz:
https://doaj.org/article/1557f01806d24dd2bc5dbaab9ea9b5dd
Autor:
Marlene Panzer, André Viveiros, Benedikt Schaefer, Nadja Baumgartner, Klaus Seppi, Atbin Djamshidian, Theodor Todorov, William J. H. Griffiths, Eckart Schott, Markus Schuelke, Dennis Eurich, Albert Friedrich Stättermayer, Adrian Bomford, Pierre Foskett, Julia Vodopiutz, Rudolf Stauber, Elke Pertler, Bernhard Morell, Herbert Tilg, Thomas Müller, Stefan Kiechl, Raul Jimenez‐Heredia, Karl Heinz Weiss, Si Houn Hahn, Andreas Janecke, Peter Ferenci, Heinz Zoller
Publikováno v:
Hepatology Communications, Vol 6, Iss 7, Pp 1611-1619 (2022)
Abstract Wilson disease (WD) is caused by biallelic pathogenic variants in adenosine triphosphatase copper‐transporting beta (ATP7B); however, genetic testing identifies only one or no pathogenic ATP7B variant in a number of patients with WD. Synon
Externí odkaz:
https://doaj.org/article/db77c899711d4cd78f551c06a74a141c
Autor:
Lorenz Balcar, Bernhard Scheiner, Markus Urheu, Patrick Weinberger, Rafael Paternostro, Benedikt Simbrunner, Lukas Hartl, Mathias Jachs, David Bauer, Georg Semmler, Claudia Willheim, Matthias Pinter, Peter Ferenci, Michael Trauner, Thomas Reiberger, Albert Friedrich Stättermayer, Mattias Mandorfer
Publikováno v:
JHEP Reports, Vol 4, Iss 11, Pp 100562- (2022)
Background & Aims: Alpha-1 antitrypsin (AAT) deficiency causes/predisposes individuals to advanced chronic liver disease (ACLD). However, the role of the SERPINA1 Pi∗Z allele in patients who have already progressed to ACLD is unclear. Thus, we aime
Externí odkaz:
https://doaj.org/article/7db32df2791c414bb06ecb495ca79f9a
Publikováno v:
Cells, Vol 11, Iss 22, p 3531 (2022)
HDV infection frequently causes progression to cirrhosis and hepatocellular carcinoma (HCC). In summer 2020, the first potentially effective drug Bulevirtide (BLV) has been approved for the treatment of HDV by the EMA. BLV is a synthetic N-acylated p
Externí odkaz:
https://doaj.org/article/2e8a9a3133464e55b695cb03586698eb
Autor:
Stephan Listabarth, Daniel König, Gabriela Berlakovich, Petra Munda, Peter Ferenci, Dagmar Kollmann, Georg Gyöeri, Thomas Waldhoer, Magdalena Groemer, Arjan van Enckevort, Benjamin Vyssoki
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 13, p 3646 (2022)
Alcohol use disorder (AUD) is one of the most important risk factors for the development of alcohol-related liver cirrhosis (ALC). Importantly, psychiatrists are an integral part of the interdisciplinary care for patients with AUD and ALC. The aim of
Externí odkaz:
https://doaj.org/article/faf3625276d8430383f172d2a2241da4
Autor:
Peter Ferenci, Jan Pfeiffenberger, Albert Friedrich Stättermayer, Rudolf E. Stauber, Claudia Willheim, Karl H. Weiss, Petra Munda-Steindl, Michael Trauner, Michael Schilsky, Heinz Zoller
Publikováno v:
JHEP Reports, Vol 1, Iss 1, Pp 2-8 (2019)
Background & Aims: HSD17B13 encodes hydroxysteroid 17-β dehydrogenase 13, a novel liver lipid-droplet associated protein that is involved in the regulation of lipid biosynthetic processes. A protein-truncating HSD17B13 variant (rs72613567) was shown
Externí odkaz:
https://doaj.org/article/88f8a0842d9949f39287a5630c81438c
Autor:
Carmen Espinós, Peter Ferenci
Publikováno v:
JHEP Reports, Vol 2, Iss 4, Pp 100114- (2020)
Summary: The diagnosis of Wilson disease is not always easy. For many patients, a combination of tests reflecting disturbed copper metabolism may be needed. Testing for ATP7B variants has become part of the routine diagnostic approach. The methods of
Externí odkaz:
https://doaj.org/article/3024d941513f4cd088e33f4497b39de9
Autor:
Georg Semmler, Teresa Binter, Karin Kozbial, Philipp Schwabl, David Chromy, David Bauer, Benedikt Simbrunner, Theresa Müllner-Bucsics, Bernhard Scheiner, Albert Stättermayer, Matthias Pinter, Petra Steindl-Munda, Michael Trauner, Peter Ferenci, Thomas Reiberger, Mattias Mandorfer
Publikováno v:
Journal of Personalized Medicine, Vol 11, Iss 4, p 281 (2021)
Genetic variants including PNPLA3-rs738409 C>G, TM6SF2-rs58542926 C>T, MBOAT7-rs641738 C>T, and HSD17B13-rs72613567 T>TA have been shown to influence progression to advanced chronic liver disease (ACLD) in patients with chronic hepatitis C (CHC). We
Externí odkaz:
https://doaj.org/article/3fab50f48f3a4dbcbb9accd236fb7050
Autor:
Edward J. Gane, Edwin DeJesus, Ewa Janczewska, Jacob George, Moises Diago, Mariliza Hendrique Da Silva, Henk Reesink, Igor Nikitin, Holger Hinrichsen, Stefan Bourgeois, Peter Ferenci, Umesh Shukla, Ronald Kalmeijer, Oliver Lenz, Bart Fevery, Chris Corbett, Maria Beumont, Wolfgang Jessner
Publikováno v:
BMC Infectious Diseases, Vol 17, Iss 1, Pp 1-13 (2017)
Abstract Background This Phase 3, open-label, rollover study (NCT01323244) investigated the efficacy and safety of simeprevir plus peginterferon α-2a (PegIFNα-2a) and ribavirin (RBV) in a well-characterized population of HCV genotype 1 (GT1)-infect
Externí odkaz:
https://doaj.org/article/3cfa6244d4a94f6ba954c69bc057268c
Autor:
Joana Vieira Barbosa, Montserrat Fraga, Joan Saldarriaga, Philippe Hiroz, Emiliano Giostra, Christine Sempoux, Peter Ferenci, Darius Moradpour
Publikováno v:
Swiss Medical Weekly, Vol 148, Iss 5152 (2018)
BACKGROUND AND AIM Wilson’s disease is an inherited disorder of hepatic copper metabolism, leading to the accumulation of copper in the liver as well as the brain, cornea and other organs. Here, we describe the adult cases of hepatic Wilson’s di
Externí odkaz:
https://doaj.org/article/9f675ed6d96944cd84263a97ba64f75b